GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 141 filers reported holding GERON CORP in Q3 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,424 | -32.6% | 48,313 | +2.0% | 0.00% | – |
| Q2 2023 | $151,994 | +66.3% | 47,350 | +12.4% | 0.00% | – |
| Q1 2023 | $91,400 | +0.1% | 42,120 | +11.6% | 0.00% | – |
| Q4 2022 | $91,316 | -75.5% | 37,734 | -76.3% | 0.00% | – |
| Q3 2022 | $372,000 | +383.1% | 159,066 | +219.1% | 0.00% | – |
| Q2 2022 | $77,000 | +8.5% | 49,841 | -0.6% | 0.00% | – |
| Q1 2022 | $71,000 | +34.0% | 50,128 | +15.1% | 0.00% | – |
| Q4 2021 | $53,000 | -13.1% | 43,555 | -2.6% | 0.00% | – |
| Q3 2021 | $61,000 | -6.2% | 44,722 | -3.2% | 0.00% | – |
| Q2 2021 | $65,000 | -12.2% | 46,182 | -1.6% | 0.00% | – |
| Q1 2021 | $74,000 | -3.9% | 46,910 | -3.0% | 0.00% | – |
| Q4 2020 | $77,000 | -4.9% | 48,371 | +4.3% | 0.00% | – |
| Q3 2020 | $81,000 | -17.3% | 46,395 | +3.4% | 0.00% | – |
| Q2 2020 | $98,000 | +40.0% | 44,879 | -23.7% | 0.00% | – |
| Q1 2020 | $70,000 | +84.2% | 58,830 | +108.5% | 0.00% | – |
| Q3 2019 | $38,000 | – | 28,211 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 23,375,839 | $49,556,779 | 7.30% |
| MPM BioImpact LLC | 10,712,481 | $22,710,460 | 6.06% |
| Ally Bridge Group (NY) LLC | 2,221,639 | $4,709,875 | 5.53% |
| Vivo Capital, LLC | 16,524,634 | $35,032,224 | 3.84% |
| NEA Management Company, LLC | 22,776,409 | $48,285,987 | 3.73% |
| Deep Track Capital, LP | 25,700,000 | $54,484,000 | 2.10% |
| RA Capital Management | 46,202,425 | $97,949,141 | 1.93% |
| Velan Capital Investment Management LP | 778,500 | $1,650,420 | 1.33% |
| Opaleye Management Inc. | 1,915,000 | $4,059,800 | 1.32% |
| Nan Fung Group Holdings Ltd | 753,550 | $1,597,526 | 1.29% |